Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | DHCR24 | Q15392 | 8/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | VDR | P11473 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28364466 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL14419156 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL29592490 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL10149106 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL10000314 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL6900716 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL665862 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL21748185 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL22150349 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL18109189 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290105-A1 | REGIOSPECIFIC INCORPORATION OF FATTY ACIDS IN TRIGLYCERIDE OIL | CHECKERSPOT, INC. (US) | 2025-09-18 | — | — | US | claimed |
| CN-119604197-A | Regiospecific incorporation of fatty acids in triglyceride oils | 格纹蛱蝶公司 | 2025-03-11 | — | — | CN | claimed |
| WO-2023212726-A2 | REGIOSPECIFIC INCORPORATION OF FATTY ACIDS IN TRIGLYCERIDE OIL | CHECKERSPOT, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| EP-0486290-B1 | A method and composition for increasing the accumulation of squalene and specific sterols in yeast | BP CORP NORTH AMERICA INC (US) | 2002-05-22 | — | — | EP | claimed |
| US-5460949-A | Increasing gene expression encoding polypeptide having HMG-CoA activity in mutant yeast; culturing | AMOCO CORPORATION (US) | 1995-10-24 | — | — | US | claimed |
| US-20250290105-A1 | REGIOSPECIFIC INCORPORATION OF FATTY ACIDS IN TRIGLYCERIDE OIL | CHECKERSPOT, INC. (US) | 2025-09-18 | — | — | US | disclosed |
| EP-4572619-A2 | MICROBIAL OILS | C16 Biosciences, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250109096-A1 | ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2025-04-03 | — | — | US | disclosed |
| EP-4208528-B1 | HIGH OLEIC OIL COMPOSITIONS AND USES THEREOF | CHECKERSPOT INC (US) | 2025-04-02 | — | — | EP | disclosed |
| CN-119604197-A | Regiospecific incorporation of fatty acids in triglyceride oils | 格纹蛱蝶公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4444858-A1 | YEAST-BASED NUTRIENT AND USES THEREOF | Danstar Ferment AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| US-20240174860-A1 | HIGH OLEIC OIL COMPOSITIONS AND USES THEREOF | CHECKERSPOT, INC. | 2024-05-30 | — | — | US | disclosed |
| US-6726911-B1 | SOLVENT EXTRACT; MICROBIOCIDES; ENDOPEPTIDASE, ANGIOTENSIN CONVERTING ENZYME AND SERUM-MEDIATED-BINDING OF LIPOPOLYSACCHARIDE INHIBITORS | GANOMYCIN (DE) | 2004-04-27 | — | — | US | disclosed |
| EP-1158995-B1 | BIOLOGICALLY ACTIVE COMPOUNDS OF GANODERMA PFEIFFERI DMS 13239 | GANOMYCIN GES FUER BIOMEDIZINI (DE) | 2003-06-18 | — | — | EP | disclosed |
| EP-0486290-B1 | A method and composition for increasing the accumulation of squalene and specific sterols in yeast | BP CORP NORTH AMERICA INC (US) | 2002-05-22 | — | — | EP | disclosed |
| EP-1158995-A1 | BIOLOGICALLY ACTIVE COMPOUNDS OF GANODERMA PFEIFFERI DMS 13239 | Ganomycin Gesellschaft für Biomedizinische Forschung mbH (DE) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000053207-A1 | BIOLOGICALLY ACTIVE COMPOUNDS OF $I(GANODERMA PFEIFFERI) DMS 13239 | GANOMYCIN GESELLSCHAFT FÜR BIOMEDIZINISCHE FORSCHUNG MBH ; (DE) | 2000-09-14 | — | — | WO | disclosed |
| US-5480805-A | Composition for modulating sterols in yeast | AMOCO CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| US-5460949-A | Increasing gene expression encoding polypeptide having HMG-CoA activity in mutant yeast; culturing | AMOCO CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| EP-0486290-A2 | A method and composition for increasing the accumulation of squalene and specific sterols in yeast | AMOCO CORPORATION (US) | 1992-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109096-A1 | ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS | LSS, ERG28, CYP51A1 | TRPV1 4582/4885CYP3A4 1361/4885DHCR24 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.